Encorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma-efectiveness and treatment reality of the European multi-centric, multinational, non-interventional study-BERING CRC

S Stintzing; H Müller-Huesmann; E von der Heyde; I Virchow; R Greil; J Kisro; P Stübs; D Bürkle; A Distelrath; J Wierecky; A Wein; Armin Gerger; D Arnold; R Fritsch; S Hegewisch-Becke; A Vogel; AD Wagner; T Winder; D Koeberle; G Prager

Encorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma-efectiveness and treatment reality of the European multi-centric, multinational, non-interventional study-BERING CRC

S Stintzing
, H Müller-Huesmann
, E von der Heyde
, I Virchow
, R Greil
, J Kisro
, P Stübs
, D Bürkle
, A Distelrath
, J Wierecky
, A Wein
, Armin Gerger
, D Arnold
, R Fritsch
, S Hegewisch-Becke
, A Vogel
, AD Wagner
, T Winder
, D Koeberle
, G Prager

Division of Oncology

Research output: Contribution to journal › Conference abstract

Original language	English
Journal	Oncology Research and Treatment
Publication status	Published - 2025
Event	Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie - Cologne, Germany Duration: 24 Oct 2025 → 27 Oct 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Links

Web of Science

Encorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma-efectiveness and treatment reality of the European multi-centric, multinational, non-interventional study-BERING CRC
Stintzing, S. (Author), Müller-Huesmann, H. (Author), von der Heyde, E. (Author), Virchow, I. (Author), Greil, R. (Author), Kisro, J. (Author), Stübs, P. (Author), Bürkle, D. (Author), Distelrath, A. (Author), Wierecky, J. (Author), Wein, A. (Author), Gerger, A. (Author), Arnold, D. (Author), Fritsch, R. (Author), Hegewisch-Becke, S. (Author), Vogel, A. (Author), Wagner, A. (Author), Winder, T. (Author), Koeberle, D. (Author) & Prager, G. (Author)
2025
Activity: Talk, presentation or poster › Poster

Cite this

Stintzing, S., Müller-Huesmann, H., von der Heyde, E., Virchow, I., Greil, R., Kisro, J., Stübs, P., Bürkle, D., Distelrath, A., Wierecky, J., Wein, A., Gerger, A., Arnold, D., Fritsch, R., Hegewisch-Becke, S., Vogel, A., Wagner, AD., Winder, T., Koeberle, D., & Prager, G. (2025). Encorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma-efectiveness and treatment reality of the European multi-centric, multinational, non-interventional study-BERING CRC. Oncology Research and Treatment.

@article{c92a5d4ce4634524b168bdfafa20e5e4,

title = "Encorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma-efectiveness and treatment reality of the European multi-centric, multinational, non-interventional study-BERING CRC",

author = "S Stintzing and H M{\"u}ller-Huesmann and \{von der Heyde\}, E and I Virchow and R Greil and J Kisro and P St{\"u}bs and D B{\"u}rkle and A Distelrath and J Wierecky and A Wein and Armin Gerger and D Arnold and R Fritsch and S Hegewisch-Becke and A Vogel and AD Wagner and T Winder and D Koeberle and G Prager",

year = "2025",

language = "English",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

publisher = "S. Karger AG",

note = "Jahrestagung der Deutschen, {\"O}sterreichischen und Schweizerischen Gesellschaften f{\"u}r H{\"a}matologie und Medizinische Onkologie ; Conference date: 24-10-2025 Through 27-10-2025",

}

Stintzing, S, Müller-Huesmann, H, von der Heyde, E, Virchow, I, Greil, R, Kisro, J, Stübs, P, Bürkle, D, Distelrath, A, Wierecky, J, Wein, A, Gerger, A, Arnold, D, Fritsch, R, Hegewisch-Becke, S, Vogel, A, Wagner, AD, Winder, T, Koeberle, D & Prager, G 2025, 'Encorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma-efectiveness and treatment reality of the European multi-centric, multinational, non-interventional study-BERING CRC', Oncology Research and Treatment.

Encorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma-efectiveness and treatment reality of the European multi-centric, multinational, non-interventional study-BERING CRC. / Stintzing, S; Müller-Huesmann, H; von der Heyde, E et al.
In: Oncology Research and Treatment, 2025.

Research output: Contribution to journal › Conference abstract

TY - JOUR

T1 - Encorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma-efectiveness and treatment reality of the European multi-centric, multinational, non-interventional study-BERING CRC

AU - Stintzing, S

AU - Müller-Huesmann, H

AU - von der Heyde, E

AU - Virchow, I

AU - Greil, R

AU - Kisro, J

AU - Stübs, P

AU - Bürkle, D

AU - Distelrath, A

AU - Wierecky, J

AU - Wein, A

AU - Gerger, Armin

AU - Arnold, D

AU - Fritsch, R

AU - Hegewisch-Becke, S

AU - Vogel, A

AU - Wagner, AD

AU - Winder, T

AU - Koeberle, D

AU - Prager, G

PY - 2025

Y1 - 2025

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:1639100700539

M3 - Conference abstract

SN - 2296-5270

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

T2 - Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie

Y2 - 24 October 2025 through 27 October 2025

ER -

Encorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma-efectiveness and treatment reality of the European multi-centric, multinational, non-interventional study-BERING CRC

UN SDGs

Links

Activities

Encorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma-efectiveness and treatment reality of the European multi-centric, multinational, non-interventional study-BERING CRC

Cite this